Stroke Card Long-term Follow-Up
Long-term Outcome of a Pragmatic Trial of Multifaceted Intervention (STROKE-CARD Care) to Reduce Cardiovascular Risk and Improve Quality-of-life After Ischemic Stroke and Transient Ischemic Attack
1 other identifier
observational
1,000
1 country
2
Brief Summary
We undertook the STROKE-CARD trial (NCT02156778) between 2014 and 2018 with follow-up until 2019 to evaluate the efficacy of the Post-Stroke disease-management program STROKE-CARD care. To further investigate the long-term efficacy of STROKE-CARD care all participants of the original trial will be invited for a Long-term in Person follow-up (3 - 6 years).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2019
CompletedStudy Start
First participant enrolled
December 16, 2019
CompletedFirst Posted
Study publicly available on registry
December 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedAugust 30, 2022
April 1, 2022
2.9 years
December 13, 2019
August 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The composite CVD outcome: nonfatal stroke (ischemic or hemorrhagic)
Recurrent stroke
through study completion, an average of 4,5 years
The composite CVD outcome: nonfatal myocardial infarction
Major recurrent (post-discharge) cardiac event
through study completion, an average of 4,5 years
The composite CVD outcome: vascular death
death resulting from an acute myocardial infarction, sudden cardiac death, death due to heart failure, stroke, cardiovascular procedures, and death due to other CV causes.
through study completion, an average of 4,5 years
self-reported health-related quality of life
quantified with the European Quality of Life 5-Dimensions 3-Levels (EQ-5D-3L) overall health utility score14 with rescaled European visual analogue scale weights.
through study completion, an average of 4,5 years
Secondary Outcomes (4)
The composite outcome of stroke/TIA
through study completion, an average of 4,5 years
all-cause mortality
through study completion at long term follow up visit, an average of 4,5 years
EQ-ED-3L
through study completion at long term follow up visit, an average of 4,5 years
Proportions of participants achieving target levels of risk factors in each trial arm of the previous STROKE-CARD trial.
through study completion at long term follow up visit, an average of 4,5 years
Study Arms (1)
STROKE CARD Cohort
Consecutive patients treated at the Department of Neurology of the University Hospital Innsbruck with ischemic stroke or high-risk TIA between 2013 and 2018 and enrolled in the Stroke Card trial, (except for those who aborted the previous trial).
Eligibility Criteria
All patients from the STROKE-CARD trial (n=2149) will be contacted by phone or mail for possible enrolment in the study. The STROKE-CARD cohort included consecutive patients with acute ischaemic stroke or TIA (ABCD2-Score ≥ 3) admitted to one of the two study centres (Medical University of Innsbruck, Hospital St. John's of God Vienna) between 2014 and 2018.
You may qualify if:
- Written informed consent
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University Innsbrucklead
- VASCage GmbHcollaborator
- Tirol Kiniken GmbHcollaborator
- Barmherzige Brüder Viennacollaborator
Study Sites (2)
Medical University of Innsbruck, Department of Neurology
Innsbruck, Tyrol, 6020, Austria
Hospital St. John's of God
Vienna, 1020, Austria
Related Publications (4)
Toell T, Boehme C, Mayer L, Krebs S, Lang C, Willeit K, Prantl B, Knoflach M, Rumpold G, Schoenherr G, Griesmacher A, Willeit P, Ferrari J, Lang W, Kiechl S, Willeit J. Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol. BMC Neurol. 2018 Nov 6;18(1):187. doi: 10.1186/s12883-018-1185-2.
PMID: 30400876RESULTBoehme C, Toell T, Mayer-Suess L, Domig L, Pechlaner R, Willeit K, Tschiderer L, Seekircher L, Willeit P, Griesmacher A, Knoflach M, Willeit J, Kiechl S. The dimension of preventable stroke in a large representative patient cohort. Neurology. 2019 Dec 3;93(23):e2121-e2132. doi: 10.1212/WNL.0000000000008573. Epub 2019 Oct 31.
PMID: 31672716RESULTKarisik A, Dejakum B, Moelgg K, Granna J, Felicetti S, Pechlaner R, Mayer-Suess L, Toell T, Buergi L, Scherer L, Willeit K, Heidinger M, Lang C, Ferrari J, Krebs S, Kleyhons R, Resch H, Willeit J, Seekircher L, Tschiderer L, Willeit P, Sykora M, Schett G, Lang W, Knoflach M, Kiechl S, Boehme C. Incidence, characteristics, and consequences of fractures after acute ischemic stroke and TIA-A prospective cohort study. Int J Stroke. 2025 Oct;20(9):1141-1149. doi: 10.1177/17474930251345300. Epub 2025 May 20.
PMID: 40391684DERIVEDBoehme C, Domig L, Komarek S, Toell T, Mayer L, Dejakum B, Krebs S, Pechlaner R, Bernegger A, Mueller C, Rumpold G, Griesmacher A, Vigl M, Schoenherr G, Schmidauer C, Ferrari J, Lang W, Knoflach M, Kiechl S. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol. BMC Cardiovasc Disord. 2022 Aug 1;22(1):347. doi: 10.1186/s12872-022-02785-5.
PMID: 35915405DERIVED
Biospecimen
Serum and whole blood sample.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Kiechl, Prof. Dr.
Medical University of Innsbruck, Austria, Department of Neurology
- PRINCIPAL INVESTIGATOR
Wilfried Lang, Prof. Dr.
Hospital St. John's of God, Vienna, Austria, Department of Neurology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2019
First Posted
December 19, 2019
Study Start
December 16, 2019
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
August 30, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share